Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Defining new clinically derived criteria for high disease activity in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study.

Backström M, Tynjälä P, Aalto K, Ylijoki H, Putto-Laurila A, Grönlund MM, Kärki J, Keskitalo P, Sard S, Pohjankoski H, Hietanen M, Witter S, Lehto H, Löyttyniemi E, Vähäsalo P.

Rheumatol Adv Pract. 2018 Oct 24;2(2):rky044. doi: 10.1093/rap/rky044. eCollection 2018.

2.

Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis.

Backström M, Tynjälä P, Aalto K, Grönlund MM, Ylijoki H, Putto-Laurila A, Kärki J, Keskitalo P, Sard S, Pohjankoski H, Hietanen M, Witter S, Lehto H, Löyttyniemi E, Vähäsalo P.

RMD Open. 2019 Apr 24;5(1):e000888. doi: 10.1136/rmdopen-2018-000888. eCollection 2019.

3.

Sulphate removal over barium-modified blast-furnace-slag geopolymer.

Runtti H, Luukkonen T, Niskanen M, Tuomikoski S, Kangas T, Tynjälä P, Tolonen ET, Sarkkinen M, Kemppainen K, Rämö J, Lassi U.

J Hazard Mater. 2016 Nov 5;317:373-384. doi: 10.1016/j.jhazmat.2016.06.001. Epub 2016 Jun 2.

PMID:
27318734
4.

Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study.

Backström M, Tynjälä P, Ylijoki H, Aalto K, Kärki J, Pohjankoski H, Keskitalo P, Sard S, Hietanen M, Lehto H, Kauko T, Vähäsalo P.

Rheumatology (Oxford). 2016 Apr;55(4):615-23. doi: 10.1093/rheumatology/kev353. Epub 2015 Oct 7. Review.

PMID:
26447164
5.

Physiotherapy students' conceptions of skill at the beginning of their Bachelor studies.

Kurunsaari M, Piirainen A, Tynjälä P.

Physiother Theory Pract. 2015 May;31(4):260-9. doi: 10.3109/09593985.2014.996692. Epub 2015 Jan 5.

PMID:
25556599
6.

Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.

Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.

Rheumatology (Oxford). 2015 Jul;54(7):1170-6. doi: 10.1093/rheumatology/keu457. Epub 2014 Dec 10.

PMID:
25504896
7.

[Medical treatment of juvenile idiopathic arthritis].

Kröger L, Vähäsalo P, Tynjälä P, Aalto K, Säilä H, Malin M, Putto-Laurila A, Lahdenne P.

Duodecim. 2012;128(5):477-86. Review. Finnish.

PMID:
22486063
8.

Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2011 Sep;70(9):1605-12. doi: 10.1136/ard.2010.143347. Epub 2011 May 28.

PMID:
21623000
9.

Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.

Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.

Scand J Rheumatol. 2011 Mar;40(2):150-2. doi: 10.3109/03009742.2010.499878. Epub 2010 Sep 26. No abstract available.

PMID:
20868307
10.

Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.

Tynjälä P, Vähäsalo P, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2009 Apr;68(4):552-7. doi: 10.1136/ard.2007.087130. Epub 2008 May 8.

PMID:
18467515
11.

Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis.

Tynjälä P, Kotaniemi K, Lindahl P, Latva K, Aalto K, Honkanen V, Lahdenne P.

Rheumatology (Oxford). 2008 Mar;47(3):339-44. doi: 10.1093/rheumatology/kem356. Epub 2008 Jan 31.

PMID:
18238789
12.

'Ain't nothin' like the real thing'. Motivation and study processes on a work-based project course in information systems design.

Helle L, Tynjälä P, Olkinuora E, Lonka K.

Br J Educ Psychol. 2007 Jun;77(Pt 2):397-411.

PMID:
17504554
13.

Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.

Tynjälä P, Lindahl P, Honkanen V, Lahdenne P, Kotaniemi K.

Ann Rheum Dis. 2007 Apr;66(4):548-50. Epub 2006 Oct 26.

14.

Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.

Tynjälä P, Lahdenne P, Vähäsalo P, Kautiainen H, Honkanen V.

Ann Rheum Dis. 2006 Aug;65(8):1044-9. Epub 2006 Jan 31.

15.

Intra-articular steroids in radiologically confirmed tarsal and hip synovitis of juvenile idiopathic arthritis.

Tynjälä P, Honkanen V, Lahdenne P.

Clin Exp Rheumatol. 2004 Sep-Oct;22(5):643-8.

PMID:
15485022

Supplemental Content

Loading ...
Support Center